We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,214
Reduced
3,562
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNTI icon
8726
Senti Biosciences Holdings
SNTI
$11.2M
$8.2K ﹤0.01%
582
-383
-40% -$9.34K
CTAQ
8727
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
$8.2K ﹤0.01%
+801
New +$8.06K
YARW
8728
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$8.2K ﹤0.01%
61
+49
+408% +$9.79K
BKHY icon
8729
BNY Mellon High Yield Beta ETF
BKHY
$161M
$8.2K ﹤0.01%
178
+78
+78% +$3.59K
PRLHU
8730
DELISTED
Pearl Holdings Acquisition Corp Unit
PRLHU
$8.18K ﹤0.01%
+800
New +$8.12K
HYBL icon
8731
State Street Blackstone High Income ETF
HYBL
$572M
$8.18K ﹤0.01%
300
-310
-51% -$8.45K
STET
8732
DELISTED
ST Energy Transition I Ltd.
STET
$8.18K ﹤0.01%
800
ACAC
8733
DELISTED
Acri Capital Acquisition Corp
ACAC
$8.17K ﹤0.01%
799
+699
+699% +$7.11K
KTTA icon
8734
Pasithea Therapeutics
KTTA
$14.7M
$8.15K ﹤0.01%
637
+364
+133% +$7.27K
AIHS icon
8735
Senmiao Technology Ltd
AIHS
$20.4M
$8.15K ﹤0.01%
905
-625
-41% -$5.64K
LEE icon
8736
Lee Enterprises
LEE
$181M
$8.13K ﹤0.01%
438
-495
-53% -$8.97K
GLBZ
8737
DELISTED
Glen Burnie Bancorp
GLBZ
$8.11K ﹤0.01%
+1,026
New +$9.34K
GXIIU
8738
DELISTED
GX Acquisition Corp. II Unit
GXIIU
$8.1K ﹤0.01%
802
ASNS
8739
DELISTED
ACTELIS NETWORKS INC
ASNS
$8.08K ﹤0.01%
168
+127
+310% +$8.09K
BICK
8740
DELISTED
First Trust BICK Index Fund
BICK
$8.08K ﹤0.01%
324
-30
-8% -$742
CODA icon
8741
Coda Octopus Group
CODA
$119M
$8.07K ﹤0.01%
1,177
-1,976
-63% -$12.5K
VALT
8742
DELISTED
ETFMG Sit Ultra Short ETF
VALT
$8.07K ﹤0.01%
167
-722
-81% -$34.7K
NTZ
8743
Natuzzi
NTZ
$13.2M
$8.07K ﹤0.01%
1,049
+549
+110% +$3.17K
AEON icon
8744
AEON Biopharma
AEON
$14.1M
$8.06K ﹤0.01%
11
-33
-75% -$23.6K
OND icon
8745
ProShares On-Demand ETF
OND
$3.51M
$8.04K ﹤0.01%
+412
New +$7.78K
MCHX icon
8746
Marchex
MCHX
$77.5M
$8.04K ﹤0.01%
5,023
+4,852
+2,837% +$8.25K
TDW.WS.A
8747
DELISTED
Tidewater Inc. Series A Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.A
$8.04K ﹤0.01%
7,373
-6,210
-46% -$5.29K
ELTX icon
8748
Elicio Therapeutics
ELTX
$85.4M
$8.04K ﹤0.01%
992
+268
+37% +$2.44K
AMZE
8749
Amaze Holdings
AMZE
$1.37M
$8.03K ﹤0.01%
+45
New +$12.5K
IPM
8750
Intelligent Protection Management Corp
IPM
$23.9M
$8.03K ﹤0.01%
6,082
-1,849
-23% -$2.76K

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.